Viewing Study NCT02877550


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-26 @ 6:42 PM
Study NCT ID: NCT02877550
Status: COMPLETED
Last Update Posted: 2022-06-10
First Post: 2016-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Sponsor:
Organization: